Print Page | Contact Us | Report Abuse | Sign In | Join
Board of Directors

There shall be twelve directors who, in addition to five officers, shall constitute the Board of Directors. There shall be balanced representation among academia, government and industry and voluntary health organizations on the Board of Directors. The Board of Directors shall manage the property and affairs of the Organization subject to these Bylaws.

 

OFFICERS

President
Thomas P. Sutula, M.D., Ph.D.
University of Wisconsin - Madison
President Elect
TBD
Secretary
TBD
Treasurer
Robert W. Hamill, M.D.
University of Vermont
College of Medicine,
Department of
Neurological Sciences
Immediate Past President
Martha Morrell, M.D.
NeuroPace, Inc
   

BOARD OF DIRECTORS

Amy S. Chappell, M.D.
Naples, FL

O’Neill D’Cruz, MD, MBA,
FAAN

OD Consulting and
Neurological Services, PLLC

 
Stewart A. Factor, DO
Emory University School
of Medicine

Toby Ferguson, MD, PhD
Biogen Idec, Inc


Bennett L, Lavenstein, MD
Co-Chair
Children’s Hospital Medical
Center

John R. Richert, MD
Richert Partners



Steven Schachter, MD
CIMIT/Harvard Medical
School
 
   

EX-OFFICIO BOARD MEMBERS

Development
Committee Chair
Martha Morrell, M.D.
NeuroPace, Inc
Neurotherapeutics®
Editor-in-Chief
M. Maral Mouradian, MD
Rutgers University
Program Committee
Chair
Stewart A. Factor, DO
Emory University School
of Medicine
NIH Blueprint Course
Liaison
Barbara Slusher, PhD, MAS
John Hopkins Brain Science
Institute
Federal Liaison
Amir Tamiz, PhD
NIH, NINDS, OTR
  Program Committee
Co-Chair

C. Anthony Altar, PhD
Neuro Drug Consulting
  Communications
Terrie Blalock, RN, MS
TBlalock Consulting
  Communications
David Shoup
The Curry Rockefeller Group
   

EXECUTIVE STAFF

Executive Director
Jessica Keenan Smith
ASENT

 










American Society for Experimental Neurotherapeutics
230 Kings Highway East, Ste 245
Haddonfield, NJ 08033
p: 833.273.6800
e: jessicasmith.asent@gmail.com

   Connect with Us